RU2007147374A - 2,8-DIMETHYL-5- [2- (4-R-Phenyl) -ethyl] -1,2,3,4-tetrahydro-1H-pyrido [4,3-b] INDOLES - MEDICAL SUBSTANCE, PHARMACEUTICAL COMPOSITION, METHODS FOR THEIR OBTAINING AND APPLICATION FOR TREATMENT OF DEPRESSIONS - Google Patents
2,8-DIMETHYL-5- [2- (4-R-Phenyl) -ethyl] -1,2,3,4-tetrahydro-1H-pyrido [4,3-b] INDOLES - MEDICAL SUBSTANCE, PHARMACEUTICAL COMPOSITION, METHODS FOR THEIR OBTAINING AND APPLICATION FOR TREATMENT OF DEPRESSIONS Download PDFInfo
- Publication number
- RU2007147374A RU2007147374A RU2007147374/04A RU2007147374A RU2007147374A RU 2007147374 A RU2007147374 A RU 2007147374A RU 2007147374/04 A RU2007147374/04 A RU 2007147374/04A RU 2007147374 A RU2007147374 A RU 2007147374A RU 2007147374 A RU2007147374 A RU 2007147374A
- Authority
- RU
- Russia
- Prior art keywords
- depression
- pharmaceutical composition
- drug substance
- treatment
- drug
- Prior art date
Links
Abstract
1. Лекарственные субстанции, обладающие нейротропной активностью по отношению к α-адреноцепторам, допаминовым D и серотониновым рецепторам ЦНС, общей формулы 1 в виде свободных оснований или в виде фармацевтически приемлемых солей, предназначенные для лечения и предупреждения депрессии. ! ! где R представляет собой атом водорода или низший алкил. ! 2. Лекарственные субстанции по п.1, представляющие собой 2,8-диметил-5-фенетил-1,2,3,4-тетрагидро-1Н-пиридо[4,3-b]индол 1.1 или его гидрохлорид 1.2, 2,8-диметил-5-[2-(4-метилфенил)-этил]-1,2,3,4-тетрагидро-1Н-пиридо[4,3-b] индол 1.3 или его гидрохлорид 1.4. ! ! 3. Фармацевтическая композиция с широким спектром рецепторспецифичной активности для лечения и/или предупреждения развития депрессии людей и теплокровных животных, содержащая фармацевтически эффективное количество лекарственной субстанции общей формулы 1 по п.1. ! 4. Фармацевтическая композиция по п.3, содержащая фармацевтически эффективное количество лекарственной субстанции по п.2. ! 5. Способ получения фармацевтической композиции по п.3 или 4 смешением с инертным наполнителем и/или растворителем, по крайней мере, одной лекарственной субстанции общей формулы 1 или ее фармацевтически приемлемой соли. ! 6. Лекарственный препарат в форме таблеток, капсул или инъекций, помещенных в фармацевтически приемлемую упаковку, включающий в свой состав лекарственную субстанцию по любому из пп.1, 2 или новую фармацевтическую композицию по любому из пп.3, 4, предназначенный для лечения и/или предупреждения депрессии. ! 7. Лекарственный препарат по п.6, предназначенный для лечения и/или предупреждения большой депрессии; эпизодической, хронической и рецидивир�1. Medicinal substances with neurotropic activity against α-adrenoceptors, dopamine D and central nervous system serotonin receptors, of the general formula 1 in the form of free bases or in the form of pharmaceutically acceptable salts, intended for the treatment and prevention of depression. ! ! where R represents a hydrogen atom or lower alkyl. ! 2. The drug substance according to claim 1, which is 2,8-dimethyl-5-phenethyl-1,2,3,4-tetrahydro-1H-pyrido [4,3-b] indole 1.1 or its hydrochloride 1.2, 2, 8-dimethyl-5- [2- (4-methylphenyl) ethyl] -1,2,3,4-tetrahydro-1H-pyrido [4,3-b] indole 1.3 or its hydrochloride 1.4. ! ! 3. A pharmaceutical composition with a wide range of receptor-specific activity for treating and / or preventing the development of depression in humans and warm-blooded animals, containing a pharmaceutically effective amount of a drug substance of the general formula 1 according to claim 1. ! 4. The pharmaceutical composition according to claim 3, containing a pharmaceutically effective amount of a drug substance according to claim 2. ! 5. A method for producing a pharmaceutical composition according to claim 3 or 4 by mixing with an inert excipient and / or solvent of at least one drug substance of general formula 1 or a pharmaceutically acceptable salt thereof. ! 6. The drug in the form of tablets, capsules or injections, placed in a pharmaceutically acceptable package, comprising a drug substance according to any one of claims 1, 2 or a new pharmaceutical composition according to any one of claims 3, 4, intended for treatment and / or prevention of depression. ! 7. The drug according to claim 6, intended for the treatment and / or prevention of major depression; episodic, chronic and relapse
Claims (8)
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2007147374/04A RU2007147374A (en) | 2007-12-21 | 2007-12-21 | 2,8-DIMETHYL-5- [2- (4-R-Phenyl) -ethyl] -1,2,3,4-tetrahydro-1H-pyrido [4,3-b] INDOLES - MEDICAL SUBSTANCE, PHARMACEUTICAL COMPOSITION, METHODS FOR THEIR OBTAINING AND APPLICATION FOR TREATMENT OF DEPRESSIONS |
US12/810,013 US20110039825A1 (en) | 2007-12-21 | 2008-12-19 | Ligands of alpha-adrenoceptors, dopamine, histamine, imidazoline and serotonin receptors and their use |
PCT/RU2008/000780 WO2009082268A2 (en) | 2007-12-21 | 2008-12-19 | LIGANDS OF α-ADRENOCEPTORS AND OF DOPAMINE, HISTAMINE, IMIDAZOLINE AND SEROTONIN RECEPTORS AND THE USE THEREOF |
JP2010539344A JP2011507835A (en) | 2007-12-21 | 2008-12-19 | Alpha-adrenergic receptor, dopamine, histamine, imidazoline and serotonin receptor ligands and uses thereof |
EP08864305A EP2236511A4 (en) | 2007-12-21 | 2008-12-19 | Ligands of alpha-adrenoceptors and of dopamine, histamine, imidazoline and serotonin receptors and the use thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2007147374/04A RU2007147374A (en) | 2007-12-21 | 2007-12-21 | 2,8-DIMETHYL-5- [2- (4-R-Phenyl) -ethyl] -1,2,3,4-tetrahydro-1H-pyrido [4,3-b] INDOLES - MEDICAL SUBSTANCE, PHARMACEUTICAL COMPOSITION, METHODS FOR THEIR OBTAINING AND APPLICATION FOR TREATMENT OF DEPRESSIONS |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2008150397/04A Substitution RU2407744C2 (en) | 2008-12-19 | 2008-12-19 | Ligands of alpha-adrenoceptors, dopamine, histamine, imidazoline and serotonin receptors and use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
RU2007147374A true RU2007147374A (en) | 2009-06-27 |
Family
ID=41026642
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2007147374/04A RU2007147374A (en) | 2007-12-21 | 2007-12-21 | 2,8-DIMETHYL-5- [2- (4-R-Phenyl) -ethyl] -1,2,3,4-tetrahydro-1H-pyrido [4,3-b] INDOLES - MEDICAL SUBSTANCE, PHARMACEUTICAL COMPOSITION, METHODS FOR THEIR OBTAINING AND APPLICATION FOR TREATMENT OF DEPRESSIONS |
Country Status (1)
Country | Link |
---|---|
RU (1) | RU2007147374A (en) |
-
2007
- 2007-12-21 RU RU2007147374/04A patent/RU2007147374A/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Sebastianutto et al. | Validation of an improved scale for rating l-DOPA-induced dyskinesia in the mouse and effects of specific dopamine receptor antagonists | |
CN108883110B (en) | Methods of treating depression using orexin-2 receptor antagonists | |
JP6419294B2 (en) | Methods of using cyclic amide derivatives to treat sigma receptor mediated disorders | |
RU2013155586A (en) | [1,3] OXASINS | |
RU2011146032A (en) | 5-HT4 RECEPTOR AGON COMPOUNDS FOR TREATMENT OF COGNITIVE DISORDERS | |
AU2005314935A1 (en) | Preventive or therapeutic agent for sleep disorder | |
KR102023748B1 (en) | Combination of pure 5-HT6 receptor antagonists and NMDA receptor antagonists | |
JP2018203774A (en) | Iloperidone metabolite for use in treatment of psychiatric disorders | |
RU2007147374A (en) | 2,8-DIMETHYL-5- [2- (4-R-Phenyl) -ethyl] -1,2,3,4-tetrahydro-1H-pyrido [4,3-b] INDOLES - MEDICAL SUBSTANCE, PHARMACEUTICAL COMPOSITION, METHODS FOR THEIR OBTAINING AND APPLICATION FOR TREATMENT OF DEPRESSIONS | |
EP3723860A1 (en) | Cyclobenzaprine treatment for agitation, psychosis and cognitive decline in dementia and neurodegenerative conditions | |
KR20190138683A (en) | Compositions and Methods for Treating Retinopathy | |
JP5714572B2 (en) | Method of modulating KCNQ potassium channel activity for the treatment of psychiatric disorders and symptoms | |
JPH09500375A (en) | Use of efaroxan and its derivatives for the manufacture of a medicament for the treatment of Parkinson's disease | |
US20230201199A1 (en) | Therapeutic drug for dyskinesia | |
JP2019509321A (en) | Combinations for treating pain | |
CN1418099A (en) | Choice compound for treatment of fibromyalgia and chronic fatigue syndrome | |
Rizek et al. | Management of Advanced Parkinson’s Disease | |
TW202345795A (en) | Pure forms of crystalline aticaprant | |
JP2021505668A (en) | Combination of NMDA receptor modulators (lapastinel) for use in combination therapies (sleep disorders and CNS disorders) | |
JP2014169247A (en) | Pharmaceutical composition for transdermal absorption | |
RU2007147376A (en) | 2,8-DIMETHYL-5 [2- (4-R-phenyl) -ethyl] -1,2,3,4-tetrahydro-1H-pyrido [4,3-b] INDOLES - MEDICINAL SUBSTANCE, PHARMACEUTICAL COMPOSITION, METHODS THEIR RECEIVING AND APPLICATIONS FOR TREATMENT OF ANXIETY DISORDERS | |
JPH07502517A (en) | Use of arylindoles for the treatment of psychosis | |
RU2007147358A (en) | 2,8-DIMETHYL-5- [2- (4-R-phenyl) -ethyl] -1,2,3,4-tetrahydro-1H-pyrido [4,3-b] ligands of ligands of dopamine receptors and their use | |
OA18659A (en) | Therapeutic Agent for Frontal Lobe Dysfunction. | |
TW200524920A (en) | Treatment of circadian rhythm disorders with NPY Y5 receptor antagonist |